NEOGEN CORP (NEOG) Form 8-K — Oct 6, 2026
Neogen reported Q1 fiscal 2027 revenue of $222.8 million, up 6.5% year over year with core growth of 8.1%, and raised full-year FY27 guidance to $885-$890 million in revenue and $181-$183 million in Adjusted EBITDA. The company posted a GAAP net loss of $11.9 million (EPS of -$0.05), though Adjusted Net Income nearly doubled to $17.5 million ($0.08 per share) and Adjusted EBITDA margin expanded to 18.7% from 17.0%, driven by higher revenue and operating leverage. Neogen remains on track to begin manufacturing saleable Petrifilm at its Lansing site in November 2026, with the first SKU fully validated.
Key figures
- Revenue
- 222800000
- Guidance
- FY27 revenue $885-$890 million and Adjusted EBITDA $181-$183 million (raised from $880-$885 million and $180-$182 million)
- Total Debt
- 774200000
- Revenue Yoy
- 6.5%
- Total Assets
- 3303200000
- Cash Position
- 172000000
- Adjusted eps
- 0.08
- Gross margin
- 47.4%
- Free cash flow
- 4700000
- Adjusted ebitda
- 41600000
- Adjusted net income
- 17500000
- Core revenue growth
- 8.1%
- Food safety revenue
- 163200000
- Operating cash flow
- 12900000
- Animal safety revenue
- 59600000
- Adjusted ebitda margin
- 18.7%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.